Hypertriglyceridemia and risk of coronary heart disease

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Lipid Metabolism

Background:

• Elevated triglyceride levels are increasingly recognized as a risk factor for coronary heart disease (CHD).
• The direct causal role of triglycerides in CHD pathogenesis remains incompletely understood.
• Hypertriglyceridemia often coexists with a cluster of metabolic abnormalities, including low HDL cholesterol, insulin resistance, and type 2 diabetes.

Purpose of the Study:

• To investigate the physiological mechanisms underlying metabolic disturbances associated with hypertriglyceridemia.
• To clarify the contribution of triglyceride levels to the overall risk of coronary heart disease.
• To explore the relationship between hypertriglyceridemia and other metabolic risk factors for cardiovascular disease.

Main Methods:

• Review of existing epidemiological and clinical studies on hypertriglyceridemia and CHD.
• Analysis of physiological pathways linking metabolic syndrome components to cardiovascular risk.
• Examination of biochemical markers associated with elevated triglycerides and their impact on endothelial function and atherosclerosis.

Main Results:

• Evidence strongly associates high triglyceride levels with increased coronary heart disease risk.
• Hypertriglyceridemia is a key feature of metabolic syndrome, characterized by insulin resistance, obesity, and dyslipidemia.
• The complex interplay of these metabolic factors likely contributes to the heightened cardiovascular risk observed in hypertriglyceridemia.

Conclusions:

• Understanding the pathophysiology of hypertriglyceridemia and its associated metabolic abnormalities is crucial for effective CHD prevention strategies.
• Further research into the causative role of triglycerides is warranted.
• Managing hypertriglyceridemia and related metabolic disturbances may be key to reducing cardiovascular risk.